1. Effect of stress on the paracellular barrier in the rat ileum. Issue 4 (1st October 2002) Authors: Mazzon, E; Sturniolo, G C; Puzzolo, D; Frisina, N; Fries, W Journal: Gut Issue: Volume 51:Issue 4(2002) Page Start: 507 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P136 Management of patients with Inflammatory Bowel Disease and their outcome during the first wave of Covid-19 pandemics. (27th May 2021) Authors: Viola, A; Giambò, F; Chiappetta, M F; Costantino, G; Pallio, S; Navarra, G; Alibrandi, A; Fries, W Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S223 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P234 Changing natural history in IBD – steroid-free remission and surgery in two cohorts (≤2009 and > 2009) – an interplay between disease pattern, biologics and adherence. (16th January 2018) Authors: Viola, A; Naim, M; Scolaro, M; Pinto-Vraca, T; Belvedere, A; Pisana, V; Costantino, G; Alibrandi, A; Fries, W Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S218 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P252 Low adherence is associated with worse disease course in Ulcerative Colitis: a retrospective study from a single referral center. (21st January 2022) Authors: Viola, A; Demarzo, M G; Abbruzzese, A; Chiappetta, M F; Costantino, G; Alibrandi, A; Fries, W Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i295 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P288 Vedolizumab May Be An Effective Option For The Management Of Postoperative Recurrence Of Crohn's Disease. (27th May 2021) Authors: Macaluso, F S; Cappello, M; Crispino, F; Grova, M; Privitera, A C; Piccillo, G; Magnano, A; Ferracane, C; Belluardo, N; Giangreco, E; Fries, W; Viola, A; Di Mitri, R; Mocciaro, F; Camilleri, S; Garufi, S; Renna, S; Casà, A; Maida, M; Orlando, A Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S320 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P305 Effectiveness and Safety of Vedolizumab in Biologic-Naïve Patients: Real-World Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD). (27th May 2021) Authors: Macaluso, F; Fries, W; Renna, S; Viola, A; Muscianisi, M; Cappello, M; Guida, L; Siringo, S; Camilleri, S; Garufi, S; Privitera, A C; Belluardo, N; Giangreco, E; Bertolami, C; Vassallo, R; Rizzuto, G; Orlando, R; Ventimiglia, M; Orlando, A Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S333 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P314 TNF gene activation used as criterion to discontinue biologic therapy – A patient series introducing the NovaPrime TNF kit. (27th May 2021) Authors: Goll, R; Kay-Martin, J; Viola, A; Paulssen, E; Moe, Ø K; Cui, G; Fries, W; Florholmen, J Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S340 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P325 A propensity score-weighted comparison of vedolizumab and adalimumab in Crohn's disease: Real-life data from the Sicilian Network for inflammatory bowel disease (SN-IBD). (15th January 2020) Authors: Macaluso, F S; Ventimiglia, M; Fries, W; Viola, A; Sitibondo, A; Cappello, M; Scrivo, B; Busacca, A; Privitera, A C; Camilleri, S; Garufi, S; Di Mitri, R; Mocciaro, F; Belluardo, N; Giangreco, E; Bertolami, C; Renna, S; Orlando, R; Rizzuto, G; Cottone, M Journal: Journal of Crohn's and colitis Issue: Volume 14(2020)Supplement 1 Page Start: S316 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P335 Treatment strategies after mucosal healing (MH) in ulcerative colitis. (15th January 2020) Authors: Sitibondo, A; Viola, A; Costantino, G; Centritto, A; Belvedere, A; Pisana, V; Abbruzzese, A; Alibrandi, A; Fries, W Journal: Journal of Crohn's and colitis Issue: Volume 14(2020)Supplement 1 Page Start: S323 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P345 The Effectiveness of Ustekinumab and Vedolizumab as Third-line Therapy in Patients with Refractory Crohn's Disease. (21st January 2022) Authors: Macaluso, F S; Grova, M; Saladino, M; Demarzo, M G; Privitera, A C; Giangreco, E; Garufi, S; Renna, S; Casà, A; Ventimiglia, M; Cappello, M; Fries, W; Orlando, A Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i359 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗